Pulmonx
PublicPulmonx is now publicly traded
The data on this page reflects Pulmonx's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Oct 5, 2020
Last Round
Debt
Mar 4, 2026
Total Funding Raised
$643.1M
Company Overview
Pulmonx operates in Healthcare and is based in Redwood City, California. Its recorded funding history includes a Debt round in May 2020.
Pulmonx is a medical technology company that provides minimally invasive treatments for patients with severe emphysema and chronic obstructive pulmonary disease.
Sector
Healthcare
AI Layer
Application
Pulmonx Comparables
Compare Pulmonx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Apreo Health | 76% | |
| Free Flow Medical, Inc. | 74% | |
| Nuvaira | 72% |
For institutional investors. Book with your work email.
Pulmonx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 4, 2026 | ||||
| Debt | Feb 1, 2023 | ||||
| IPO | Oct 5, 2020 | ||||
| Debt | May 5, 2020 | ||||
| Convertible Debt | May 5, 2020 | ||||
Series G | May 9, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pulmonx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Perceptive Advisors | Debt |
| Canaccord Genuity | IPO |
| Ally Bridge Group | Convertible Debt, Series G |
| MedVenture Associates | Series A, Series D, Series C, Series B, Series E |
| Linea Investment | Series C |
| BofA Securities | IPO |
| CIBC Innovation Banking | Debt, Convertible Debt |
For institutional investors. Book with your work email.
Pulmonx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.